Nanodiamond delivery circumvents tumor resistance to doxorubicin

Acta Pharmacol Sin. 2011 May;32(5):543-4. doi: 10.1038/aps.2011.58. Epub 2011 May 2.

Authors

Xiao-wei Ma¹, Yu-liang Zhao, Xing-jie Liang

Affiliation

¹ Laboratory of Nanomedicine and Nanosafety, Division of Nanomedicine and Nanobiology, National Center for Nanoscience and Technology, China.

No abstract available

MeSH terms

Animals
Antibiotics, Antineoplastic / administration & dosage*
Antibiotics, Antineoplastic / pharmacology
Doxorubicin / administration & dosage*
Doxorubicin / pharmacology
Drug Delivery Systems
Drug Resistance, Neoplasm
Humans
Nanodiamonds*
Neoplasms / drug therapy
Neoplasms / pathology

Substances

Antibiotics, Antineoplastic
Nanodiamonds
Doxorubicin